We are live on ! Find out more
MF

Magnetar Financial Portfolio holdings

AUM $9.84B
1-Year Est. Return 190.64%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+190.64%
3 Year Est. Return
+293.18%
5 Year Est. Return
+491.79%
10 Year Est. Return
+5,174.28%
AUM
$4.8B
AUM Growth
+$330M
Cap. Flow
+$1.96B
Cap. Flow %
40.8%
Top 10 Hldgs %
23.01%
Holding
660
New
296
Increased
60
Reduced
83
Closed
163

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$111M
2
SOLV icon
Solventum
SOLV
+$87.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$82.2M
4
CHX
ChampionX
CHX
+$74.8M
5
SRCL
Stericycle Inc
SRCL
+$72.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.01%
2 Technology 8.53%
3 Financials 7.15%
4 Industrials 6.63%
5 Energy 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRO
26
DELISTED
Marathon Oil Corporation
MRO
$63.6M 1.33%
+2,216,804
New +$61.5M
CI icon
27
Cigna
CI
$76.6B
$62.8M 1.31%
190,119
+26,783
+16% +$9.24M
AMED
28
DELISTED
Amedisys
AMED
$56.5M 1.18%
615,495
-3,416
-0.6% -$317K
CTLT
29
DELISTED
CATALENT, INC.
CTLT
$56M 1.17%
995,550
-4,078
-0.4% -$227K
MRK icon
30
Merck
MRK
$324B
$53.6M 1.12%
433,099
+229,927
+113% +$29.6M
SILK
31
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$53.3M 1.11%
+1,970,373
New +$41M
OLK
32
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$52M 1.08%
2,040,732
-8,319
-0.4% -$198K
DO
33
DELISTED
Diamond Offshore Drilling, Inc.
DO
$51.4M 1.07%
+3,319,173
New +$47.3M
TMO icon
34
Thermo Fisher Scientific
TMO
$211B
$51M 1.06%
+92,254
New +$52.9M
ENOV icon
35
Enovis
ENOV
$1.56B
$49.9M 1.04%
1,104,803
+442,051
+67% +$22.9M
HTLF
36
DELISTED
Heartland Financial USA, Inc.
HTLF
$46.6M 0.97%
+1,048,965
New +$42.5M
FTRE icon
37
Fortrea Holdings
FTRE
$1.85B
$46.3M 0.97%
1,985,854
+1,381,489
+229% +$42.9M
LIVN icon
38
LivaNova
LIVN
$4.3B
$44.6M 0.93%
814,452
+61,114
+8% +$3.48M
VZIO
39
DELISTED
VIZIO Holding Corp.
VZIO
$42.8M 0.89%
3,959,576
ADMA icon
40
ADMA Biologics
ADMA
$1.92B
$41.5M 0.87%
3,712,258
-947,120
-20% -$7.95M
CERE
41
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$41.5M 0.86%
1,014,239
-4,189
-0.4% -$174K
MCK icon
42
McKesson
MCK
$98.5B
$37.5M 0.78%
64,269
-39,647
-38% -$22.1M
RPT
43
Rithm Property Trust
RPT
$90.5M
$35.1M 0.73%
1,639,035
WIRE
44
DELISTED
Encore Wire Corp
WIRE
$35.1M 0.73%
+121,066
New +$34.1M
NWLI
45
DELISTED
National Western Life Group, Inc. Class A
NWLI
$33.5M 0.7%
67,482
HSIC icon
46
Henry Schein
HSIC
$9.74B
$32.7M 0.68%
510,610
+124,152
+32% +$8.74M
DXCM icon
47
DexCom
DXCM
$27.6B
$31.8M 0.66%
+280,407
New +$35.5M
RBCP
48
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
$31.6M 0.66%
260,000
BSX icon
49
Boston Scientific
BSX
$65.8B
$30M 0.63%
389,375
+141,330
+57% +$10.3M
HA
50
DELISTED
Hawaiian Holdings, Inc.
HA
$29.7M 0.62%
2,392,800

Similar funds

Magnetar Financial's Q2 2024 Portfolio in Review

As of Q2 2024, Magnetar Financial held 660 positions worth $4.8B, up 7.4% from $4.47B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Magnetar Financial deployed $1.96B of net new capital in Q2 2024, opening 296 new positions and adding to 60 existing holdings. Its largest new stake was Johnson & Johnson: 552,484 shares worth $80.8M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 44% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Medtronic, an estimated $98.6M trimmed.

  • Magnetar Financial's largest Q2 2024 buy was Johnson & Johnson: 552,484 shares worth $80.8M.
  • Magnetar Financial added most to Sanofi in Q2 2024, an estimated $111M increase.
  • Magnetar Financial's biggest Q2 2024 reduction was Medtronic, cutting an estimated $98.6M.
  • Magnetar Financial fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $92.6M.
  • Magnetar Financial's ten largest holdings make up 23% of its $4.8B portfolio in Q2 2024.
  • Magnetar Financial opened 296 new positions and closed 163 in Q2 2024.
  • Magnetar Financial's portfolio value rose 7.4% quarter-over-quarter to $4.8B.

Based on Magnetar Financial's 13F filing for Q2 2024, filed 14 Aug 2024.